Project Details
| Status | Active |
|---|---|
| Effective start/end date | 05/5/25 → 02/3/27 |
Funding
- Nkarta Incorporated: $29,751.00
Ntrust-2: A Phase 1 Study of NKX019, a CD19 Chimeric Antigen Receptor Natural Killer (CAR NK) Cell Therapy in Subjects with Immune-Mediated Diseases
- Schuster, Michael (PI)
- Gabig, Theodore (CoPI)
- Jandl, Thomas (CoPI)
- Lan, Fengshuo (CoPI)
- Lee, Christina (CoPI)
- Liu, Suhu (CoPI)
Project: Research